Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 1

Interventions

pembrolizumab 1251 Specimen Handling 867 Carboplatin 816 Magnetic Resonance Spectroscopy 803 Cyclophosphamide 794 Cisplatin 715 Nivolumab 646 Paclitaxel 623 Radiotherapy 564 Gemcitabine 562 Biopsy 529 Bevacizumab 468 Dexamethasone 433 fludarabine 404 Docetaxel 370 venetoclax 365 Oxaliplatin 362 Fluorouracil 352 Capecitabine 350 atezolizumab 341 Rituximab 326 durvalumab 326 Doxorubicin 313 Radiosurgery 305 Pemetrexed 302 Drug Therapy 294 Standard of Care 292 Ipilimumab 289 Etoposide 279 Radiation 277

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Engineering × 1 year × Clear all

NCT07366658 2026-01-26

NEUK203-13

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 1 Not yet recruiting

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡